EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $224,750 | -18.3% | 31,000 | 0.0% | 0.04% | -22.2% |
| Q4 2022 | $274,970 | +116.5% | 31,000 | +198.1% | 0.04% | +104.5% |
| Q3 2022 | $127,000 | +3.3% | 10,400 | 0.0% | 0.02% | +4.8% |
| Q2 2022 | $123,000 | -37.9% | 10,400 | 0.0% | 0.02% | -44.7% |
| Q1 2022 | $198,000 | -28.3% | 10,400 | 0.0% | 0.04% | -37.7% |
| Q4 2021 | $276,000 | -63.9% | 10,400 | -44.1% | 0.06% | -63.7% |
| Q3 2021 | $764,000 | -56.5% | 18,600 | -40.0% | 0.17% | -53.8% |
| Q2 2021 | $1,756,000 | +190.2% | 31,000 | +115.3% | 0.36% | +191.2% |
| Q1 2021 | $605,000 | -71.9% | 14,400 | -53.2% | 0.12% | -77.9% |
| Q4 2020 | $2,156,000 | +0.4% | 30,750 | -59.8% | 0.56% | -0.5% |
| Q3 2020 | $2,147,000 | -28.8% | 76,500 | -25.0% | 0.57% | -26.1% |
| Q2 2020 | $3,017,000 | +48.4% | 102,000 | -0.5% | 0.77% | +40.3% |
| Q1 2020 | $2,033,000 | +3.3% | 102,500 | +54.1% | 0.55% | -12.6% |
| Q4 2019 | $1,969,000 | – | 66,500 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |